B cells and antibodies in the defense against Mycobacterium tuberculosis infection
- PMID: 25703559
- PMCID: PMC4629253
- DOI: 10.1111/imr.12276
B cells and antibodies in the defense against Mycobacterium tuberculosis infection
Abstract
Better understanding of the immunological components and their interactions necessary to prevent or control Mycobacterium tuberculosis (Mtb) infection in humans is critical for tuberculosis (TB) vaccine development strategies. Although the contributory role of humoral immunity in the protection against Mtb infection and disease is less defined than the role of T cells, it has been well-established for many other intracellular pathogens. Here we update and discuss the increasing evidence and the mechanisms of B cells and antibodies in the defense against Mtb infection. We posit that B cells and antibodies have a variety of potential protective roles at each stage of Mtb infection and postulate that such roles should be considered in the development strategies for TB vaccines and other immune-based interventions.
Keywords: B lymphocytes; antibodies; immunity; immunoglobulins; tuberculosis.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures

Similar articles
-
Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.Tuberculosis (Edinb). 2017 Sep;106:25-32. doi: 10.1016/j.tube.2017.06.001. Epub 2017 Jun 8. Tuberculosis (Edinb). 2017. PMID: 28802401
-
Antibodies and tuberculosis: finally coming of age?Nat Rev Immunol. 2018 Sep;18(9):591-596. doi: 10.1038/s41577-018-0028-0. Nat Rev Immunol. 2018. PMID: 29872140 Review.
-
Antibody-mediated immunity against tuberculosis: implications for vaccine development.Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009. Cell Host Microbe. 2013. PMID: 23498951 Free PMC article. Review.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Cold Spring Harb Perspect Med. 2014 Oct 9;5(3):a018432. doi: 10.1101/cshperspect.a018432. Cold Spring Harb Perspect Med. 2014. PMID: 25301934 Free PMC article. Review.
Cited by
-
Next-Generation Vaccines Based on Bacille Calmette-Guérin.Front Immunol. 2018 Feb 5;9:121. doi: 10.3389/fimmu.2018.00121. eCollection 2018. Front Immunol. 2018. PMID: 29459859 Free PMC article. Review.
-
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.Front Immunol. 2023 Aug 17;14:1244556. doi: 10.3389/fimmu.2023.1244556. eCollection 2023. Front Immunol. 2023. PMID: 37662901 Free PMC article. Review.
-
RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies.Vaccines (Basel). 2020 Feb 4;8(1):67. doi: 10.3390/vaccines8010067. Vaccines (Basel). 2020. PMID: 32033104 Free PMC article. Review.
-
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals.Front Immunol. 2024 Dec 9;15:1427559. doi: 10.3389/fimmu.2024.1427559. eCollection 2024. Front Immunol. 2024. PMID: 39717773 Free PMC article. Review.
-
Identification of autoimmune markers in pulmonary tuberculosis.Front Immunol. 2023 Jan 25;13:1059714. doi: 10.3389/fimmu.2022.1059714. eCollection 2022. Front Immunol. 2023. PMID: 36761174 Free PMC article.
References
-
- World Health Organization . Global tuberculosis report 2014. Geneva, Switzerland: 2014. http://www.who.int/tb/publications/global_report/en/
-
- Colditz GA, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Jama. 1994;271:698–702. - PubMed
-
- Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173–1180. - PubMed
-
- Rook GA, Hernandez-Pando R. The pathogenesis of tuberculosis. Annu Rev Microbiol. 1996;50:259–284. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI033142/AI/NIAID NIH HHS/United States
- R01 AI096213/AI/NIAID NIH HHS/United States
- AI-033142/AI/NIAID NIH HHS/United States
- R01 AI033774/AI/NIAID NIH HHS/United States
- P01 AI063537/AI/NIAID NIH HHS/United States
- AI-096213/AI/NIAID NIH HHS/United States
- R21 AI105684/AI/NIAID NIH HHS/United States
- P30 AI051519/AI/NIAID NIH HHS/United States
- R01 HL059842/HL/NHLBI NIH HHS/United States
- AI-094745/AI/NIAID NIH HHS/United States
- AI-51519/AI/NIAID NIH HHS/United States
- R01 AI094745/AI/NIAID NIH HHS/United States
- HL-059842/HL/NHLBI NIH HHS/United States
- AI-063537/AI/NIAID NIH HHS/United States
- AI-033774/AI/NIAID NIH HHS/United States
- R01 AI052733/AI/NIAID NIH HHS/United States
- 1U18 FD004012/01/FD/FDA HHS/United States
- UL1 TR001073/TR/NCATS NIH HHS/United States
- U18 FD004012/FD/FDA HHS/United States
- R37 AI033142/AI/NIAID NIH HHS/United States
- AI-052733/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical